Commentary on Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer

2009 ◽  
Vol 27 (6) ◽  
pp. 692 ◽  
Author(s):  
Daniel W. Lin
Keyword(s):  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Phase 1 ◽  
High Dose ◽  
Phase 1 Trial ◽  
Castration Resistant

scholarly journals Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

2009 ◽  
Vol 56 (2) ◽  
pp. 237-244 ◽  
Author(s):  
Michael J. Morris ◽  
Daisy Huang ◽  
William K. Kelly ◽  
Susan F. Slovin ◽  
Ryan D. Stephenson ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Phase 1 ◽  
High Dose ◽  
Phase 1 Trial ◽  
Castration Resistant

A Phase 1 Trial of Cabazitaxel Combined With 188Re–Hydroxyethylidene Diphosphonate in Patients With Metastatic Castration-Resistant Prostate Cancer Who Progressed on or After a Docetaxel-Containing Treatment

2017 ◽  
Vol 42 (6) ◽  
pp. 415-420 ◽  
Author(s):  
Joyce M. van Dodewaard-de Jong ◽  
Esther W. Bouman-Wammes ◽  
Haiko J. Bloemendal ◽  
Henk M.W. Verheul ◽  
John M.H. de Klerk ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase 1 ◽  
Castration Resistant Prostate Cancer ◽  
Phase 1 Trial ◽  
Castration Resistant

Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis

2020 ◽  
Author(s):  
Abdilkerim Oyman ◽  
Mustafa Başak ◽  
Melike Özçelik ◽  
Deniz Tataroğlu Özyükseler ◽  
Selver Işık ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Data Analysis ◽  
Real World ◽  
Metastatic Prostate Cancer ◽  
Abiraterone Acetate ◽  
Real World Data ◽  
World Data ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document